![Margaret McGlynn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Margaret McGlynn
Chairman at
NOVAVAX, INC.
Net worth: 418 889 $ as of 30/06/2026
Profile
Margaret G.
McGlynn is currently Chairman at Novavax, Inc. since 2025, Chairman & President at HCU Network America since 2016, Director at Abington Friends School, Director at Life Science Cares Philadelphia, and Trustee at University at Buffalo Foundation, Inc. Former roles include President, Chief Executive Officer & Director at International AIDS Vaccine Initiative, Inc. from 2011 to 2015; Independent Director at Air Products & Chemicals, Inc. from 2005 to 2020; Director at Quidel Corp.; Independent Director at Vertex Pharmaceuticals, Inc. from 2011 to 2023; Director at GAVI Alliance from 2006 to 2008; Director at Orphan Technologies Ltd.; Independent Director at Amicus Therapeutics, Inc. from 2009 to 2026; President-Global Vaccines & Infectious Disease at Merck & Co., Inc. from 2006 to 2009; and President at US Department of Health & Human Services in 2005.
Education includes an undergraduate degree (1981) and an MBA (1983) from State University of New York at Buffalo.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NOVAVAX, INC. 0.03% | 20/06/2026 | 44,468 ( 0.03% ) | 418 889 $ | 30/06/2026 |
Margaret McGlynn active positions
| Companies | Position | Start |
|---|---|---|
| NOVAVAX, INC. | Chairman | 10/03/2025 |
Abington Friends School
 Abington Friends School Other Consumer ServicesConsumer Services Provides primary and secondary education services | Director/Board Member | - |
HCU Network America
 HCU Network America Services to the Health IndustryHealth Services Provides support services for patients and families | Chairman | 01/06/2016 |
Life Science Cares Philadelphia | Director/Board Member | - |
University at Buffalo Foundation, Inc. | Director/Board Member | - |
Former positions of Margaret McGlynn
| Companies | Position | End |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Director/Board Member | 27/04/2026 |
| VERTEX PHARMACEUTICALS INCORPORATED | Director/Board Member | 17/05/2023 |
| AIR PRODUCTS & CHEMICALS, INC. | Director/Board Member | 23/11/2020 |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops vaccines for AIDS | Chief Executive Officer | 08/09/2015 |
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Margaret McGlynn
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
82
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Air Products & Chemicals, Inc.
 Air Products & Chemicals, Inc. Chemicals: SpecialtyProcess Industries Manufactures and supplies oxygen, nitrogen, argon, hydrogen, helium & carbon dioxide gases | Process Industries |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Quidel Corp.
 Quidel Corp. Medical SpecialtiesHealth Technology Provides diagnostic healthcare solutions | Health Technology |
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Novavax, Inc.
 Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops vaccines for AIDS | Health Technology |
GAVI Alliance
 GAVI Alliance Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
State University of New York at Buffalo
 State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Department of Health & Human Services
 US Department of Health & Human Services General GovernmentGovernment Governmental department | Government |
University at Buffalo Foundation, Inc. | Consumer Services |
Abington Friends School
Abington Friends School Other Consumer ServicesConsumer Services Provides primary and secondary education services | Consumer Services |
Orphan Technologies Ltd.
 Orphan Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs | Health Technology |
HCU Network America
HCU Network America Services to the Health IndustryHealth Services Provides support services for patients and families | Health Services |
Life Science Cares Philadelphia |
- Stock Market
- Insiders
- Margaret McGlynn
